Furthermore, Chugai has been selected as a constituent of 'DJSI Asia Pacific,' the
DJSI is a leading ESG index developed by
In the pharmaceutical sector of the 'DJSI World,' the top eight sustainable companies have been selected as constituents, including Chugai, which received the third highest sustainability rating among pharmaceutical companies in the world. 323 companies (including 39 Japanese companies) have been selected for the
In the mid-term business plan IBI 21 which runs for three years starting from 2019, Chugai has set 'Strengthen Sustainable Platforms' as one of the five strategies that support our challenge toward innovation. We have specified six priority areas to realize the creation of shared values with society. Based on the gap analysis of external ESG assessments such as DJSI, we are working to continuously strengthen the sustainable platforms by implementing the PDCA cycle centered on the above six areas. As a result, this year's sustainability scores of human rights due diligence for suppliers and supply chain management far exceeded last year.
Based on the business philosophy of 'Innovation all for the patients,' Chugai is committed to actively fulfill our social responsibilities as a healthcare company by adding exceptional value through the creation of innovative medical products and services for the benefit of the medical community and human health around the world.
Contact:
Tel: +81-3-3273-0881
Email: pr@chugai-pharm.co.jp
(C) 2020 Electronic News Publishing, source